pubmed-article:18275516 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C0004057 | lld:lifeskim |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C0162595 | lld:lifeskim |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C2921106 | lld:lifeskim |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C1446409 | lld:lifeskim |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C0521114 | lld:lifeskim |
pubmed-article:18275516 | lifeskim:mentions | umls-concept:C1514923 | lld:lifeskim |
pubmed-article:18275516 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:18275516 | pubmed:dateCreated | 2008-2-15 | lld:pubmed |
pubmed-article:18275516 | pubmed:abstractText | It is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss. However, it is unclear if occasional antiphospholipid antibodies (aPL) are a risk factor and whether patients with aPL at one time point but not diagnosed as APS should be treated. | lld:pubmed |
pubmed-article:18275516 | pubmed:language | eng | lld:pubmed |
pubmed-article:18275516 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18275516 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18275516 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18275516 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18275516 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18275516 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18275516 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18275516 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18275516 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18275516 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18275516 | pubmed:month | Mar | lld:pubmed |
pubmed-article:18275516 | pubmed:issn | 1046-7408 | lld:pubmed |
pubmed-article:18275516 | pubmed:author | pubmed-author:SatoTakeshiT | lld:pubmed |
pubmed-article:18275516 | pubmed:author | pubmed-author:SuzumoriNobuh... | lld:pubmed |
pubmed-article:18275516 | pubmed:author | pubmed-author:Sugiura-Ogasa... | lld:pubmed |
pubmed-article:18275516 | pubmed:author | pubmed-author:OzakiYasuhiko... | lld:pubmed |
pubmed-article:18275516 | pubmed:author | pubmed-author:NakanishiTama... | lld:pubmed |
pubmed-article:18275516 | pubmed:author | pubmed-author:KumagaiKyokoK | lld:pubmed |
pubmed-article:18275516 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18275516 | pubmed:volume | 59 | lld:pubmed |
pubmed-article:18275516 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18275516 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18275516 | pubmed:pagination | 235-41 | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:meshHeading | pubmed-meshheading:18275516... | lld:pubmed |
pubmed-article:18275516 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18275516 | pubmed:articleTitle | Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. | lld:pubmed |
pubmed-article:18275516 | pubmed:affiliation | Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, Aichi, Japan. og.mym@med.nagoya-cu.ac.jp | lld:pubmed |
pubmed-article:18275516 | pubmed:publicationType | Journal Article | lld:pubmed |